Dublin, Ireland, based biopharmaceutical company Mallinckrodt plc reports that its INOmax (nitric oxide) vasodilator inhalation device has received regulatory approval in Australia and Japan for treating pulmonary hypertension in conjunction with heart surgery. The Australian Therapeutic Goods Administration (TGA) has approved INOmax…
Social Clips
https://www.youtube.com/watch?v=oGYqr1vzFfI Cordelia Skuldt has had Pulmonary Hypertension since she was 4. She is here to challenge you today to take the Blue Lip Kiss challenge to raise awareness and money for this horrible disease. 1. Take a photo of yourself with blue lips, and post it on social media (Facebook,…
Fox Sports writer/producer Steve Van Wormer takes us through his son Lucas Van Wormer’s fight to create awareness for Pulmonary Hypertension. He also wants to make more people phaware. What is pulmonary hypertension? Pulmonary hypertension is a rare, debilitating disease of the lungs that affects the functioning of the heart…
“It’s a hassle remembering what times I have to take my meds now, and cleaning all of the equipment and whatnot. I really hope that this medicine helps … I just find it a huge distraction.” “It makes me upset that pulmonary hypertension is holding me…
Complexa Inc., a biopharmaceutical company developing therapies to treat fibrosis and inflammation-related diseases, announced the successful completion of a Phase 1 clinical program for its lead drug candidate CXA-10, and the beginning of preparations for Phase 2 clinical trials for focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH) in 2016.
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of orphan diseases and conditions with ineffective current treatments, announced a new license agreement with a leading Japanese pharmaceutical company, Nippon Kayaku. Eiger BioPharmaceuticals aims to develop Nippon Kayaku’s therapeutic drug Bestatin™ (ubenimex) for the…
Read the articles here: 1. Therapy Options Exist for PAH Patients Unresponsive to Medications 2. CTEPH Found To Be Underdiagnosed; Survey Reveals Need for Greater Physician Awareness 3. Technique Found To Stabilize Pulmonary Artery Pressure in PH Animal Model…
The American Heart Association (AHA) and American Thoracic Society (ATS) have issued new guidelines pertaining to Pediatric Pulmonary Hypertension. The revisions come as a result of collaboration between the agencies and were developed in a joint effort by an interdisciplinary team of 27 experienced clinicians and…
Lips Painted Blue is a series of animated videos about Jeremy, a little boy that found out he had Pulmonary Hypertension. Learn more about PH: https://bit.ly/1K4oewk…
The Burbank, California-based non-profit organization phaware is a global association dedicated to creating awareness about pulmonary hypertension through engagement and technological innovation to discover and chart the course to a cure. Pulmonary hypertension (PH) is a rare, chronic lung disease that affects the functioning of the heart and…
Pulmonary hypertension (PH) is a rare lung disorder that causes constricting and clogging of the pulmonary arteries that are used to conduct blood from the heart to the lungs. Since the disease causes difficulties for the heart to properly pump the blood, the organ needs to work…
According to a Bucks Herald article, Santa Claus will parade through Aylesbury (England) on Sunday, November 29 before ending up at the Friars Square Christmas grotto. The grotto will charge £3 entry for one child and a £5 charge for two or more, with all proceeds will be going…
